Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer.

Autor: Cui R; Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China., Wang C; Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China., Zhao Q; Tianjin Medical University, Tianjin, China., Wang Y; Department of Clinical Laboratory Medicine, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang Province, China., Li Y; Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China.

Publikováno v: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2020; Vol. 20 (17), pp. 2053-2065.

Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice.

Autor: Morser J; Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA., Shao Z; Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA., Nishimura T; Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA., Zhou Q; Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA., Zhao L; Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA., Higgins J; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Leung LLK; Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2018 May; Vol. 16 (5), pp. 991-1002. Date of Electronic Publication: 2018 Apr 06.

Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice.

Autor: Zhou Q; Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA., Zhao L; Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA., Shao Z; Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA., Declerck P; Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Leung LLK; Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA., Morser J; Division of Hematology, Stanford University School of Medicine, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jan; Vol. 20 (1), pp. 238-244. Date of Electronic Publication: 2021 Nov 07.

Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.

Autor: Hu X; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Wetsel RA; Brown Foundation Institute of Molecular Medicine and Department of Biochemistry and Molecular Biology, University of Texas Medical School at Houston, Houston, TX 77030, USA., Ramos TN; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Mueller-Ortiz SL; Brown Foundation Institute of Molecular Medicine and Department of Biochemistry and Molecular Biology, University of Texas Medical School at Houston, Houston, TX 77030, USA., Schoeb TR; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Barnum SR; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: sbarnum@uab.edu.

Publikováno v: Immunobiology [Immunobiology] 2014 Feb; Vol. 219 (2), pp. 104-8. Date of Electronic Publication: 2013 Aug 23.

Comparative Proteomic Investigation of Plasma Reveals Novel Potential Biomarker Groups for Acute Aortic Dissection.

Autor: Cheng N; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China.; The Department of Health Care for Cadres, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001 Xinjiang, China., Wang H; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China., Zhang W; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China., Wang H; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China., Jin X; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China.; Shenzhen Omics Medical Research Center, Shenzhen, 518053 Guangdong, China., Ma X; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Heart Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China., Ma Y; The Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China.; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Heart Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054 Xinjiang, China.

Publikováno v: Disease markers [Dis Markers] 2020 Mar 18; Vol. 2020, pp. 4785068. Date of Electronic Publication: 2020 Mar 18 (Print Publication: 2020).